- Home
- FORR vs GNFT Comparison
FORR vs GNFT Comparison
Compare FORR & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FORR
- GNFT
- Stock Information
- Founded
- FORR 1983
- GNFT 1999
- Country
- FORR United States
- GNFT France
- Employees
- FORR N/A
- GNFT N/A
- Industry
- FORR Diversified Commercial Services
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FORR Consumer Discretionary
- GNFT Health Care
- Exchange
- FORR Nasdaq
- GNFT Nasdaq
- Market Cap
- FORR 185.3M
- GNFT 186.3M
- IPO Year
- FORR 1996
- GNFT 2019
- Fundamental
- Price
- FORR $9.94
- GNFT $3.92
- Analyst Decision
- FORR
- GNFT Strong Buy
- Analyst Count
- FORR 0
- GNFT 2
- Target Price
- FORR N/A
- GNFT $11.00
- AVG Volume (30 Days)
- FORR 83.1K
- GNFT 3.9K
- Earning Date
- FORR 11-04-2025
- GNFT 09-22-2025
- Dividend Yield
- FORR N/A
- GNFT N/A
- EPS Growth
- FORR N/A
- GNFT N/A
- EPS
- FORR N/A
- GNFT 0.03
- Revenue
- FORR $412,103,000.00
- GNFT $73,187,701.00
- Revenue This Year
- FORR N/A
- GNFT $5.15
- Revenue Next Year
- FORR $1.51
- GNFT N/A
- P/E Ratio
- FORR N/A
- GNFT $129.22
- Revenue Growth
- FORR N/A
- GNFT 105.01
- 52 Week Low
- FORR $8.50
- GNFT $2.55
- 52 Week High
- FORR $19.74
- GNFT $6.42
- Technical
- Relative Strength Index (RSI)
- FORR 51.98
- GNFT 46.69
- Support Level
- FORR $9.40
- GNFT $3.85
- Resistance Level
- FORR $9.90
- GNFT $4.16
- Average True Range (ATR)
- FORR 0.35
- GNFT 0.13
- MACD
- FORR 0.03
- GNFT -0.04
- Stochastic Oscillator
- FORR 61.16
- GNFT 9.95
About FORR Forrester Research Inc.
Forrester Research Inc provides independent research, data, and advisory services. It operates through the following segments: The Research segment develops and delivers research, connect, and analytics products; The consulting segment includes the revenues and the related costs of the company's consulting organization, and the Events segment is engaged in developing and hosting in-person and virtual events.
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.